Shire bags $850m loan for NPS takeover
Shire, the Dublin-headquartered biopharmaceutical company, has secured an $850m fully underwritten short term bank facility to help finance its takeover agreement for NPS Pharmaceuticals of the US.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts